Antibe Therapeutics Inc(Pre-Merger) ATBPF

RE:stock price looks terrible

[Jefferam1]

This is my take on the reason. 
There is no reason for the price too shoot up right now thus it is going down.
If a pharma was truly going to bite the bullet and take its chances on Antibe after the last result, it would be happening as we speak. Bidding war would have started and the price would reflect that.
Since this seems to not be the case, at this point, it is more likely Pharma are waiting for next Trial to be complete as it will further de-risk this product. Sure that means the asking price will be up but it also means less risk.
OK so these numbers are not representative but just used to draw a dramatic effect on my explanation. Would you rather pay $1 for something that has a 40% chance of succeeding or 2$ for something that has a 60% of success or possibly 4$ for something that has a 95% chance of success if the end target is $20. I'd say 4$ with 95% chance of it going to $20 looks pretty good.
The next big event is the next Phase 2b trial due end of year. That's the likely time to draw a lot of attention. Sure there maybe be some regional deals before then, but at this point I expect the next catalyst is efficacy study. I don't expect there to be much new blood before then. Since all the longs are already long, this will linger.
What does this say? It pretty much says no movement for 6-7 months. As such people will exit which will bring price down.
Does this mean ATE is only worth 0.40 or less? Absolutely not. It is undervalued, but no panic or rush for people to get in so this will continue to linger in the meantime. That sucks for us. But all the same I'm not about to rush off and sell. Price fluctuation can drop to 0.35 maybe lower. Can also bounce back to 0.50 or higher. (wow those comment was rocket science, ok I realize I'm an idiot the share price can virtually go to anything.). But what I'm getting at is the main problem, there is no new blood in the game. Citagenix will continue to suck, no new short term catalyst to draw more people into this. We are going to be in a dog fight for the next 6 months.
I think the only thing that can turn this around in the short term is a high profile analyst picking up coverage of this stock which draws a lot more people in. Short of that, I think this will be a stock to simply ignore. Let it go up and down and wait for year end. (And I'm not gonna follow my own advice as I'll still be checking daily and disappointed with the dips).
Ok guys let's have it. I'm ready to be chewed up and spitted out over my comments.